Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

COVID vaccine trials were a triumph – now we need a similar system for antibiotics

By Claas Kirchhelle, Lecturer in the History of Medicine, University College Dublin
Rebecca Glover, Research Fellow, Health Services Research and Policy, London School of Hygiene & Tropical Medicine
Share this article
The triumph of COVID-19 vaccine development and the discovery of effective treatments was only possible because of the unprecedented coordination of clinical trials. A process of testing – that often lasts over a decade – was compressed into less than nine months. This should now be the model for other major planetary health crises – namely, antimicrobial resistance (AMR).

To stay ahead of, and rapidly respond to, non-viral microbial threats, we believe it is time for a new forward-looking clinical trials…


Read complete article

© The Conversation -


Follow us on ...
Facebook Twitter